The following information is presented by Genesys Health System.

Print The Page
Genesys Heart Institute
One Genesys Parkway
Grand Blanc, MI 48439
Fax: 810-606-6235

This is where the area's best heart care lives.
    Our Heart Team approach ensures that our patients receive the highest level of personalized treatment options and care from our cardiovascular physicians and clinical staff.
      Here’s how we’re saving more hearts than any other hospital in the region:
      • Nationally ranked cardiac specialists, nurses and clinicians work hand in hand for your heart
      • Leader in technological advances, clinical research and complex heart procedures
      • Performing more minimally invasive heart surgeries than any other hospital in the region
      • Four new Cardiac Catheterization Labs with enhanced imaging and state-of-the-art monitoring capabilities. Our patients benefit from cutting-edge technology as we perform advanced procedures and tackle complex cases.

      Don’t just take our word for it—here’s what others are saying:
      • Awarded a 3-star rating from the Society of Thoracic Surgeons, the highest possible rating for quality. This places us in the top 15% in the nation for heart surgery care.
      • Designated as a “Total Value” Blue Distinction Center+ for Cardiac Care with Blue Cross Blue Shield, recognizing Genesys for nationally established quality care and outcomes criteria

      New treatment for heart valve disease:
      Transcatheter Aortic Valve Replacement (TAVR)
      Over five million Americans are diagnosed each year with heart valve disease, many of whom suffer from aortic stenosis, which is a narrowing of the heart’s aortic valve. Once symptoms develop, aortic stenosis is a life-threatening condition that progresses rapidly. Chest pain, fatigue, shortness of breath, lightheadedness and fainting are not always the symptoms of age or slowing down. It can be something more serious. It’s important to be screened by a cardiologist, and if needed, to receive treatment quickly.

      For patients who are considered high-risk or too sick for open-heart valve surgery, Genesys Heart Institute physicians can perform the innovative Transcatheter Aortic Valve Replacement procedure, or TAVR. This groundbreaking procedure replaces the aortic valve using a catheter-based approach. The minimally invasive procedure provides a much shorter recovery time with less pain, while dramatically improving a patient’s quality of life.

      Now there is hope and you have treatment options. Genesys Heart Institute Valve Clinic physicians focus on all aspects of heart disease, including a complete range of heart valve screenings and the latest treatment options. To schedule your appointment, call Genesys Heart Institute at (888) 463-3268.

      From no hope to new hope
      See how Genesys Heart Institute is changing the lives of atrial fibrillation sufferers with the breakthrough Convergent procedure, including that of a recent patient. 

      Convergent procedure offers new hope for atrial fibrillation patients

      For long-suffering atrial fibrillation (AFib) patients, the physicians of the Genesys Heart Institute are the first and only in Michigan to offer the Convergent procedure. This new and innovative treatment option is for patients with persistent or difficult to treat AFib who have not been successful with conventional ablation techniques.

      Previously, these patients were left with no options, and often, no hope. Combining the skills of a cardiothoracic surgeon and an electrophysiologist in a single procedure, Convergent is a minimally invasive treatment option that can correct an irregular heartbeat and get patients back to the quality of life they deserve.

      Candidates for the Convergent procedure include those living with symptomatic, persistent AFib (episodes lasting more than one week) who have had a recurrence of AFib despite medications intended to maintain normal rhythm. In particular, the Convergent procedure is intended for patients with structural heart disease, who have a moderately to severely enlarged heart (specifically the upper chambers of the heart called the atria), and who have failed previous conventional ablation procedures.

      To meet with our expert team of cardiologists to discuss your treatment options, including the Convergent procedure, call the Genesys Heart Institute at (888) 463-3268.  

      Experts in treating atrial fibrillation
      Atrial fibrillation is a rapid and irregular heart rhythm (heartbeat) that arises from chaotic and irregular electrical activity in the upper chambers of the heart. If the heart rate is left at a rapid pace for long periods, the heart muscle weakens, leading to symptoms of congestive heart failure and a higher risk for stroke.

      Genesys Heart Institute offers the region’s only Atrial Fibrillation Clinic, providing our patients with evidence-based, cutting-edge therapies provided by a team of highly trained electrophysiologists, cardiologists, surgeons and cardiac specialists.

      Our team is equipped to provide state-of-the-art treatments and individualized care plans designed to restore and maintain normal heart rhythm. Working with your primary care physician and/or cardiologist, our cardiac specialists provide the most advanced AFib treatment options available. This includes an emphasis on patient education, an assessment for the risk of stroke and access to a dedicated nurse navigator who is there to guide you through all steps of your care.

      Cutting-edge cases performed in new cardiac catheterization labs
      Genesys has invested nearly $10 million to renovate three cardiac catheterization labs and create one entirely new catheterization lab. Each lab features enhanced imaging equipment, state-of-the-art monitoring capabilities, radiation reduction technology and an electrophysiology “cockpit” to integrate the lab’s equipment. These advancements provide our patients with the latest generation of technology and allow our physicians to perform more complex catheter-based procedures including laser lead extractions, endovascular grafts and the new Convergent procedure.